Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant pleural mesothelioma--an update.

Duncan J Stewart1, John G Edwards, W Roy Smythe

  • 1University Department of Oncology, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.

International Journal of Occupational and Environmental Health
|April 9, 2004
PubMed
Summary

Malignant mesothelioma, often caused by asbestos exposure, presents with various symptoms and diagnostic challenges. Current treatments offer variable impacts, but multimodality approaches and new therapies show promise for improved patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial intelligence-enabled histological analysis in pre-clinical respiratory disease models: a scoping review.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Safety of intravascular administration of umbilical-cord-derived mesenchymal stromal cells: an updated systematic review and meta-analysis.

Stem cells translational medicine·2026
Same author

Regulatory T-cell based therapies for acute lung injury: a systematic review and meta-analysis.

American journal of respiratory cell and molecular biology·2026
Same author

Targeted Intra-Atrial Delivery of GMP-Grade Human Extracellular Vesicles Prevents Inflammation-Driven Postoperative Atrial Fibrillation in Pigs.

JACC. Basic to translational science·2026
Same author

Cellular immunotherapy for COVID-19-induced acute respiratory distress syndrome: Results of the CIRCA-19 phase 1 safety and phase 2 randomized controlled trials.

Stem cell reports·2026
Same author

A potency and toxicology study on tolerability of cryopreserved mesenchymal stem cell product with DMSO in septic mice and nude rats.

Molecular therapy. Methods & clinical development·2025

Area of Science:

  • Oncology
  • Pulmonology
  • Environmental Health

Background:

  • Malignant mesothelioma is primarily linked to asbestos exposure, presenting with symptoms like dyspnea and chest pain.
  • Diagnosis can be challenging due to histologic difficulties and inconsistent disease staging.
  • Conventional treatments (chemotherapy, surgery, radiotherapy) have shown variable efficacy.

Purpose of the Study:

  • To review the current understanding of malignant mesothelioma.
  • To discuss diagnostic challenges and treatment modalities.
  • To explore future directions and potential improvements in patient care.

Main Methods:

  • Review of existing literature on malignant mesothelioma.
  • Analysis of clinical features, diagnostic techniques, and treatment outcomes.

Related Experiment Videos

  • Evaluation of emerging therapeutic strategies and prognostic markers.

    • Main Results:

    • Chemotherapy offers palliation and can improve survival and quality of life.
    • Multimodality treatments are most successful for potentially resectable disease.
    • New radiotherapeutic techniques and antimetabolite agents show promise.

    Conclusions:

    • Accurate staging and prognosis may be improved by biological markers.
    • A better understanding of disease biology fuels cautious optimism for future treatments.
    • Multimodality treatment strategies are key for managing malignant pleural mesothelioma.